Страна: Сінгапур
мова: англійська
Джерело: HSA (Health Sciences Authority)
DOXAZOSIN MESYLATE 2.43MG EQV DOXAZOSIN
VIATRIS PRIVATE LIMITED
C02CA04
2 mg
TABLET
DOXAZOSIN MESYLATE 2.43MG EQV DOXAZOSIN 2 mg
ORAL
Prescription Only
Pfizer Manufacturing Deutschland GmbH
ACTIVE
1990-08-16
PFIZER CARDURA * Doxazosin Mesylate 1. NAME OF THE MEDICINAL PRODUCT CARDURA 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredient: doxazosin The tablets contain doxazosin mesylate salt equivalent to 1 mg, 2 mg and 4 mg doxazosin. 3. PHARMACEUTICAL FORM Tablets 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS _Hypertension_ Doxazosin is indicated for the treatment of hypertension and can be used as the initial agent to control blood pressure in the majority of patients. In patients not adequately controlled on a single antihypertensive agent, doxazosin may be used in combination with another agent, such as a thiazide diuretic, a beta-blocker, a calcium antagonist or an angiotensin-converting enzyme inhibitor. _Benign Prostatic Hyperplasia_ Doxazosin is also indicated for the treatment of the urinary outflow obstruction and symptoms associated with benign prostatic hyperplasia (BPH). Doxazosin may be used in BPH patients who are either hypertensive or normotensive. While the blood pressure changes in normotensive patients with BPH are clinically insignificant, patients with hypertension and BPH have had both conditions effectively treated with doxazosin monotherapy. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Doxazosin may be administered either in the morning or in the evening. _Hypertension_ The full dosage range of doxazosin is 1 mg to 16 mg daily. It is recommended that therapy be initiated at 1 mg once daily for 1 or 2 weeks to minimize the potential for postural hypotension and/or syncope (see section 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE). The dosage may then be increased to 2 mg once daily for an additional 1 or 2 weeks. If necessary, the daily dosage should then be increased gradually at similar intervals to 4 mg, 8 mg, and 16 mg, as determined by patient response, to achieve the desired reduction in blood pressure. The usual dose is 2 mg to 4 mg once daily. _Benign Prostatic Hyperplasia_ The recommended initial dosage of doxazosin is 1 mg once daily to minimize the potential for postural Прочитайте повний документ
CARDURA ® Doxazosin Mesylate 1. NAME OF THE MEDICINAL PRODUCT CARDURA 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredient: doxazosin The tablets contain doxazosin mesylate salt equivalent to 1 mg, 2 mg and 4 mg doxazosin. 3. PHARMACEUTICAL FORM Tablets 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS _Hypertension_ Doxazosin is indicated for the treatment of hypertension and can be used as the initial agent to control blood pressure in the majority of patients. In patients not adequately controlled on a single antihypertensive agent, doxazosin may be used in combination with another agent, such as a thiazide diuretic, a beta-blocker, a calcium antagonist or an angiotensin-converting enzyme inhibitor. _Benign Prostatic Hyperplasia_ Doxazosin is also indicated for the treatment of the urinary outflow obstruction and symptoms associated with benign prostatic hyperplasia (BPH). Doxazosin may be used in BPH patients who are either hypertensive or normotensive. While the blood pressure changes in normotensive patients with BPH are clinically insignificant, patients with hypertension and BPH have had both conditions effectively treated with doxazosin monotherapy. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Doxazosin may be administered either in the morning or in the evening. _Hypertension_ The full dosage range of doxazosin is 1 mg to 16 mg daily. It is recommended that therapy be initiated at 1 mg once daily for 1 or 2 weeks to minimize the potential for postural hypotension and/or syncope (see section 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE ). The dosage may then be increased to 2 mg once daily for an additional 1 or 2 weeks. If necessary, the daily dosage should then be increased gradually at similar intervals to 4 mg, 8 mg, and 16 mg, as determined by patient response, to achieve the desired reduction in blood pressure. The usual dose is 2 mg to 4 mg once daily. _Benign Prostatic Hyperplasia_ The recommended initial dosage of doxazosin is 1 mg once daily to minimize the potential for postural hypot Прочитайте повний документ